Position in VTRS
as of Jun 30, 2026
· filed Aug 21, 2026
Position Value
$79,225,415
+$68,645,275 QoQ
Shares Held
4,989,006
+537.1% QoQ
Ownership
0.434%
of shares outstanding
% of Portfolio
0.10%
of 13F equity value
Holder Rank
#33
of 1,016 holders
Holding Since
Sep 2021
20 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in VTRS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Assenagon Asset Management S.A. holds $514,912,865 across 20 Drug Manufacturers - Specialty & Generic names. VTRS ranks #3 (15.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TEVA |
Teva Pharmaceutical Industries Ltd
|
3,056,017 | $103,537,855 | |
| 2 | LNTH |
Lantheus Holdings, Inc.
|
714,980 | $79,319,881 | |
| 3 | VTRS |
Viatris Inc
This page
|
4,989,006 | $79,225,415 | |
| 4 | INDV |
Indivior Pharmaceuticals, Inc.
|
1,540,928 | $63,224,275 | |
| 5 | UTHR |
UNITED THERAPEUTICS Corp
|
84,538 | $45,805,224 | |
| 6 | AMRX |
Amneal Pharmaceuticals, Inc.
|
2,445,549 | $42,332,453 | |
| 7 | NBIX |
Neurocrine Biosciences Inc
|
222,606 | $37,518,015 | |
| 8 | ZTS |
Zoetis Inc.
|
389,335 | $27,977,613 |
All Filings in VTRS
Export CSV
20 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $79,225,415 | 4,989,006 | Shares | Sole | 2026-08-21 | |
| 2026-03-31 | $10,580,140 | 783,134 | Shares | Sole | 2026-04-20 | |
| 2025-12-31 | $44,504,815 | 3,574,684 | Shares | Sole | 2026-01-09 | |
| 2025-09-30 | $8,707,327 | 879,528 | Shares | Sole | 2025-10-07 | |
| 2025-06-30 | $35,473,987 | 3,972,451 | Shares | Sole | 2025-07-11 | |
| 2025-03-31 | $6,167,429 | 708,086 | Shares | Sole | 2025-04-15 | |
| 2024-12-31 | $7,786,566 | 625,427 | Shares | Sole | 2025-01-14 | |
| 2024-09-30 | $10,758,510 | 926,659 | Shares | Sole | 2024-10-23 | |
| 2024-06-30 | $7,840,103 | 737,545 | Shares | Sole | 2024-07-18 | |
| 2024-03-31 | $9,679,531 | 810,681 | Shares | Sole | 2024-04-24 | |
| 2023-12-31 | $24,889,072 | 2,298,160 | Shares | Sole | 2024-01-17 | |
| 2023-09-30 | $7,269,393 | 737,261 | Shares | Sole | 2023-11-06 | |
| 2023-06-30 | $3,461,882 | 346,882 | Shares | Sole | 2023-07-25 | |
| 2023-03-31 | $12,520,295 | 1,301,486 | Shares | Sole | 2023-04-18 | |
| 2022-12-31 | $19,693,744 | 1,769,429 | Shares | Sole | 2023-01-12 | |
| 2022-09-30 | $15,612,942 | 1,832,505 | Shares | Sole | 2022-10-27 | |
| 2022-06-30 | $22,670,240 | 2,165,257 | Shares | Sole | 2022-07-27 | |
| 2022-03-31 | $2,832,074 | 260,301 | Shares | Sole | 2022-04-25 | |
| 2021-12-31 | $1,325,141 | 97,941 | Shares | Sole | 2022-02-01 | |
| 2021-09-30 | $52,742,724 | 3,892,452 | Shares | Sole | 2021-10-19 | |
| No filing history on record for this holder in this stock. | ||||||